Africa's public health agency announced on 6 August 2026 a major escalation of the Ebola response in the Democratic Republic of the Congo, with confirmed cases surpassing 4,000 and health officials raising concerns that the virus may be mutating. Dr Jean Kaseya, director general of Africa CDC, told a press briefing that the time for incremental action was over and that response teams would go "door to door" looking for patients (The Guardian).

The DRC's national public health institute recorded 3,973 cases and 1,801 deaths as of 4 August. The outbreak, caused by the Bundibugyo strain of the virus, was first reported on 15 May, though there are suspicions the disease could have been spreading since January. It is now the second-largest Ebola outbreak on record. Ituri province, the conflict-affected mining region where the outbreak is centred, and Nord-Kivu, Sud-Kivu, Haut-Uele, and Tshopo provinces have all reported cases. Neighbouring Uganda recorded 20 cases before bringing its outbreak under control (The Guardian).

The trajectory dwarfs the early phase of the 2014–18 West Africa Ebola outbreak, which ultimately infected more than 28,000 people and killed at least 11,000. Eleven weeks into this outbreak, the DRC had already recorded eight times more cases and six times more deaths than the West Africa outbreak had at the same point (The Guardian).

Kaseya said he and WHO director general Tedros Adhanom Ghebreyesus planned studies to determine whether the virus is mutating, because the severity level of this Bundibugyo outbreak is unprecedented. The Bundibugyo strain has historically been associated with lower case fatality — meaning a smaller share of infected people die — than the Zaire ebolavirus strain responsible for the 2014–18 epidemic, making the current mortality and case counts all the more alarming to virologists and outbreak responders.

Several operational indicators point to a response that is not keeping pace with transmission. More than two-thirds of Ebola deaths are occurring in the community rather than in treatment centres, a sign that patients are not being identified and isolated quickly enough to prevent onward transmission. At an MSF treatment centre in Bunia, capital of Ituri province, 90% of admitted patients do not appear on authorities' lists of contacts of known Ebola cases (The Guardian). MSF is actively responding to the outbreak in both the DRC and Uganda (Doctors Without Borders).

Contact tracing — the practice of finding and monitoring everyone who has been near a confirmed patient, which is the backbone of Ebola containment — is acutely insufficient. Kaseya said only 10 contacts are being identified for every Ebola patient when approximately 40 would be expected. Dr Wessam Mankoula, acting head of emergency preparedness and response at Africa CDC, said response teams planned a shift "from contact tracing to active case search," with community health workers moving door to door asking households if anyone was sick with Ebola symptoms (The Guardian).

Kaseya promised a "village-centered response" involving communities, more use of digital tools, and greater action in camps for people internally displaced by conflict in affected provinces. The DRC is facing one of the world's worst humanitarian crises, compounded by an outbreak for which no licensed vaccine exists (International Rescue Committee).

On the treatment and prevention front, officials said they planned to begin using the antiviral remdesivir on a compassionate use basis — meaning giving an unapproved drug to seriously ill patients when no alternatives are available — to treat Ebola patients. They also planned to test whether Ervebo, the vaccine licensed for use against the Zaire ebolavirus strain, should be offered in the affected provinces. Data suggesting that Bundibugyo caused less serious disease and "zero death" among people who had received the Ervebo jab has prompted the evaluation, though the vaccine is not currently approved for this strain (The Guardian).

Dr Placide Mbala Kingebeni, Africa CDC director of research, clinical trials and innovation, said public health measures alone would not be enough to quickly control or stop the outbreak given its expansion (The Guardian).

The continental architecture has been mobilising for weeks. Africa CDC and WHO launched a Continental Preparedness and Response Plan for Ebola to coordinate containment and preparedness across African Union Member States, with a joint response plan aiming to raise $518 million to strengthen outbreak response measures through November 2026 (CIDRAP; Africa CDC). The US CDC states it is responding to the outbreak, which is spreading substantially in the DRC and Uganda (US CDC).

The broader context here is one of a response apparatus confronting a pathogen that is outpacing the conventional toolkit. The West Africa outbreak was eventually contained through a massive deployment of international resources, contact tracing at scale, and the rapid development and deployment of vaccines. In the DRC, the operational environment is considerably more hostile: active conflict, displacement, and infrastructure gaps in Ituri and the Kivus complicate access to affected populations, while the absence of a licensed vaccine for the Bundibugyo strain removes a critical pillar of the response. The decision to pivot from contact tracing to active case search is an implicit acknowledgment that the standard approach of breaking chains of transmission by following each patient's contacts has broken down. Whether door-to-door surveillance can compensate for the shortfall in contact identification, in provinces where armed groups operate and trust in authorities is fragile, will likely determine whether this outbreak rivals or surpasses the 2014–18 catastrophe. The planned mutation studies add another variable: if the virus is adapting in ways that increase transmissibility or virulence, the calculus for both clinical and public health response changes considerably.